We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.02T
$3.85B 5.94%
22,098,810
-159,300
-0.7% -$29.2M
AAPL icon
2
Apple
AAPL
$4.81T
$3.31B 5.11%
13,046,454
-180,100
-1% -$46.9M
MSFT icon
3
Microsoft
MSFT
$2.95T
$2.43B 3.75%
6,575,643
-51,500
-0.8% -$21.5M
AMZN icon
4
Amazon
AMZN
$2.66T
$1.91B 2.94%
9,156,260
+91,500
+1% +$20.1M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.24T
$1.5B 2.31%
5,215,600
-38,200
-0.7% -$12M
AVGO icon
6
Broadcom
AVGO
$1.84T
$1.27B 1.96%
4,112,056
-110,000
-3% -$36.2M
META icon
7
Meta Platforms (Facebook)
META
$1.63T
$1.18B 1.82%
2,059,335
+42,900
+2% +$27.5M
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.22T
$1.18B 1.82%
4,104,520
-74,600
-2% -$23.4M
TSLA icon
9
Tesla
TSLA
$1.42T
$898M 1.38%
2,414,500
-58,300
-2% -$24M
LLY icon
10
Eli Lilly
LLY
$1.02T
$880M 1.36%
956,817
+124,525
+15% +$126M
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.06T
$804M 1.24%
1,677,769
+34,300
+2% +$16.8M
COP icon
12
ConocoPhillips
COP
$143B
$795M 1.23%
6,019,177
-1,018,100
-14% -$113M
JPM icon
13
JPMorgan Chase
JPM
$918B
$710M 1.1%
2,415,266
-13,200
-0.5% -$4.01M
JNJ icon
14
Johnson & Johnson
JNJ
$599B
$602M 0.93%
2,463,008
+252,095
+11% +$58.7M
RVMD icon
15
Revolution Medicines
RVMD
$38.4B
$533M 0.82%
5,475,611
+3,270,056
+148% +$330M
CVX icon
16
Chevron
CVX
$381B
$517M 0.8%
2,500,766
+720,600
+40% +$131M
WMT icon
17
Walmart Inc
WMT
$878B
$455M 0.7%
3,662,026
-211,300
-5% -$25.9M
V icon
18
Visa
V
$677B
$450M 0.69%
1,489,040
-18,300
-1% -$5.88M
PG icon
19
Procter & Gamble
PG
$345B
$407M 0.63%
2,816,973
-5,247
-0.2% -$795K
COST icon
20
Costco
COST
$412B
$396M 0.61%
397,677
+8,100
+2% +$7.89M
XOM icon
21
ExxonMobil
XOM
$629B
$376M 0.58%
2,218,922
-442,800
-17% -$64.6M
MU icon
22
Micron Technology
MU
$1.1T
$374M 0.58%
1,105,603
-5,200
-0.5% -$2.04M
RPRX icon
23
Royalty Pharma
RPRX
$25.4B
$359M 0.55%
7,480,633
-4,259,961
-36% -$187M
MA icon
24
Mastercard
MA
$484B
$357M 0.55%
713,610
-16,950
-2% -$8.93M
CNTA
25
DELISTED
Centessa Pharmaceuticals
CNTA
$355M 0.55%
8,925,010
-2,356,731
-21% -$60.3M
1
2 3 4 5

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.